Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission: a Cluster Randomized Trial
Phase of Trial: Phase IV
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Therapeutic Use
- Acronyms RHOST
- 17 Nov 2016 Planned primary completion date changed from 1 Jul 2018 to 1 Aug 2018.
- 17 Nov 2016 Status changed from not yet recruiting to recruiting.
- 07 Sep 2016 New trial record